HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Antimicrobial activity of cefetamet against fresh clinical isolates of Branhamella catarrhalis].

Abstract
Against strains of Branhamella catarrhalis which were separated from various RTIs (respiratory tract infections) in 1991 antimicrobial activities (MICs) of cefetamet (CFMT) were determined, and the following conclusions were obtained. 1. The MIC80 of CFMT against B. catarrhalis was 0.39 microgram/ml, which was higher than that of cefixime (CFIX) by one dilution or twofold, but was lower than that of cefpodoxime (CPDX) by two dilutions or fourfold and that of cefotiam (CTM) by three dilutions or eightfold. 2. The fact that all of the 50 strains tested were beta-lactamase producers appeared to indicate that CFMT was stable against BRO-1 and BRO-2 beta-lactamases produced by B. catarrhalis. 3. Blood concentrations of the test drug, CFMT, and control drugs upon normal single doses were calculated using pharmacokinetic parameters. Lengths of time periods during which drug concentrations stayed above their MICs against B. catarrhalis obtained in this study were determined for CFMT, CFIX, CPDX and CTM. They were, respectively, 12 hours, 12 hours, 6 hours, and 2 hours, thus CFMT appeared to remain above MIC for sufficiently long time for the treatment of RTIs which are affected by B. catarrhalis directly or indirectly.
AuthorsK Deguchi, N Yokota, M Koguchi, Y Nakane, Y Suzuki, S Fukayama, R Ishihara, S Oda
JournalThe Japanese journal of antibiotics (Jpn J Antibiot) Vol. 45 Issue 4 Pg. 359-63 (Apr 1992) ISSN: 0368-2781 [Print] Japan
PMID1518118 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • cefetamet
  • cefpodoxime
  • Cefotiam
  • Cefixime
  • Ceftizoxime
  • beta-Lactamases
  • Cefotaxime
Topics
  • Cefixime
  • Cefotaxime (analogs & derivatives, pharmacokinetics, pharmacology)
  • Cefotiam (pharmacokinetics, pharmacology)
  • Ceftizoxime (analogs & derivatives, pharmacokinetics, pharmacology)
  • Drug Resistance, Microbial
  • Drug Stability
  • Humans
  • Moraxella catarrhalis (drug effects, enzymology, isolation & purification)
  • Respiratory Tract Infections (microbiology)
  • beta-Lactamases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: